Lannett Enters Into Distribution Agreement For Generic ADVAIR DISKUS® |
| October 01, 2019 | October 2019 Bond Updates |
|
PHILADELPHIA, Oct. 1, 2019 /PRNewswire/ -- Lannett Company, Inc. (NYSE: LCI) today announced that it has entered into an exclusive U.S. distribution agreement for the therapeutically equivalent generic of ADVAIR DISKUS® (Fluticasone Propionate – Salmeterol Xinafoate Powder Inhaler) of... |
| View more at: https://www.prnewswire.com:443/news-releases/lannett-enters-into-distribution-agreement-for-generic-advair-diskus-300928052.html |
| Related News |